Correlation Between Renaissance IPO and Innovator IBD

Can any of the company-specific risk be diversified away by investing in both Renaissance IPO and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Renaissance IPO and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Renaissance IPO ETF and Innovator IBD 50, you can compare the effects of market volatilities on Renaissance IPO and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Renaissance IPO with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Renaissance IPO and Innovator IBD.

Diversification Opportunities for Renaissance IPO and Innovator IBD

0.83

Correlation Coefficient

Renaissance IPO  Innovator IBD

Very poor diversification

The 3 months correlation between Renaissance and Innovator is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Renaissance IPO ETF and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and Renaissance IPO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Renaissance IPO ETF are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of Renaissance IPO i.e., Renaissance IPO and Innovator IBD go up and down completely randomly.

Pair Corralation between Renaissance IPO and Innovator IBD

Considering the 90-day investment horizon Renaissance IPO ETF is expected to generate 0.7 times more return on investment than Innovator IBD. However, Renaissance IPO ETF is 1.44 times less risky than Innovator IBD. It trades about -0.07 of its potential returns per unit of risk. Innovator IBD 50 is currently generating about -0.08 per unit of risk. If you would invest  4,592  in Renaissance IPO ETF on October 1, 2024 and sell it today you would lose (111.00) from holding Renaissance IPO ETF or give up 2.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Renaissance IPO ETF  vs.  Innovator IBD 50

Renaissance IPO ETF

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Renaissance IPO ETF are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Renaissance IPO may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Innovator IBD 50

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Innovator IBD showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Renaissance IPO and Innovator IBD

The main advantage of trading using opposite Renaissance IPO and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Renaissance IPO position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.

The idea behind Renaissance IPO ETF and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.